EUVIMEDEUVIMED entdecken
Crossref

Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury

Zengtao Song, Zhaoliang Ban, Haosen Zhao, Xifan Mei

Neurochemistry International · 2026-07 · 197 · 106171

DOI: 10.1016/j.neuint.2026.106171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2026-07. Verfasst von Zengtao Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, 121000, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Oligopeptides, Mitochondria, Recovery of Function. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) induces secondary damage characterized by mitochondrial dysfunction, oxidative stress, and apoptosis, which collectively impede neurological recovery. Elamipretide (SS-31) is a mitochondria-targeting peptide with potential neuroprotective effects. Here, we investigated whether SS-31 improves functional outcomes after contusive SCI and explored associated mechanisms. In a mouse thoracic contusion model, SS-31 treatment significantly enhanced locomotor recovery and gait performance. Histological analyses showed reduced lesion pathology and increased neuronal preservation in the injured spinal cord. Early after injury, SS-31 attenuated apoptosis signaling, evidenced by reduced cleaved caspase-3 and Bax and increased Bcl-2. At the chronic stage, SS-31 was associated with diminished astrogliosis and enhanced markers of axonal and synaptic remodeling. In oxidatively stressed PC12 cells, SS-31 preserved mitochondrial membrane potential, reduced ROS accumulation, and supported oxidative phosphorylation-related protein integrity. Collectively, these findings suggest that SS-31 promotes recovery after SCI, potentially by mitigating early apoptotic injury and supporting mitochondrial homeostasis and neural remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesOligopeptidesMitochondriaRecovery of FunctionEnergy MetabolismNeuroprotective AgentsNeuronal PlasticityAnimalsMicePC12 CellsApoptosisFemaleRatsOxidative StressMice, Inbred C57BL

Stichwörter der Autor:innen

ApoptosisElamipretide (SS-31)Mitochondrial dysfunctionNeural remodelingOxidative stressSpinal cord injury

Substanzen

elamipretideOligopeptidesNeuroprotective Agents

Autor:innen und Institutionen

  • Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, 121000, China.
  • First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, 121000, China.
  • Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, 121000, China. Electronic address: 275551919@qq.com.
  • Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, 121000, China. Electronic address: meixifan@jzmu.edu.cn.

Zitieren

APA

Song, Z., Ban, Z., Zhao, H., & Mei, X. (2026). Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury. Neurochemistry International, 197, 106171. https://doi.org/10.1016/j.neuint.2026.106171

Vancouver

Song Z, Ban Z, Zhao H, Mei X. Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury. Neurochemistry International. 2026;197:106171. doi:10.1016/j.neuint.2026.106171

BibTeX
@article{Song2026,
  author = {Song, Zengtao and Ban, Zhaoliang and Zhao, Haosen and Mei, Xifan},
  title = {Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury},
  journal = {Neurochemistry International},
  year = {2026},
  volume = {197},
  pages = {106171},
  doi = {10.1016/j.neuint.2026.106171}
}
Kostenlos starten →